Nexalin shareholders approve reverse split, equity plan; reject preferred shares and exculpation

Nexalin Technology, Inc.

All five director nominees elected: Bernhard, White, Owens, Kazden, Hu with 8.7-8.8M votes each; quorum 63.2%.
Reverse stock split approved: 12,458,652 for vs 1,401,464 against; ratios 1-for-2 to 1-for-100, up to 1-for-250 aggregate.
2026 Equity Incentive Plan approved: 8,248,630 for, 815,467 against.
Proposal to authorize 10M preferred shares failed: 7,863,517 for, 1,208,690 against.
Officer exculpation amendment failed: 8,239,359 for, 772,759 against; auditor ratification passed 13,362,297 for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.